CBT Pharmaceuticals啟動APOLLO腫瘤臨床試驗計畫
September 18, 2018 08:50 ET
|
CBT Pharmaceuticals
美國加利福尼亞州普萊森頓與中國杭州, Sept. 18, 2018 (GLOBE NEWSWIRE) -- CBT...
CBT Pharmaceuticals启动APOLLO肿瘤临床试验计划
September 18, 2018 08:50 ET
|
CBT Pharmaceuticals
美国加利福尼亚州普莱森顿和中国杭州, Sept. 18, 2018 (GLOBE NEWSWIRE) -- 致力于成为肿瘤联合疗法发现与开发领域的领军者并在中美两国均设有总部的创新性生物制药公司CBT...
CBT Pharmaceuticals Initiates the APOLLO Oncology Clinical Trials Program
September 18, 2018 08:50 ET
|
CBT Pharmaceuticals
PLEASANTON, Calif. and HANGZHOU, China, Sept. 18, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT), a U.S. and China-based innovative biopharmaceutical company committed to becoming a leader in...
CBT Pharmaceuticals公佈全新的領導層架構，旨在推動全球擴張
August 16, 2018 09:50 ET
|
CBT Pharmaceuticals
美國加利福尼亞州普萊森頓, Aug. 16, 2018 (GLOBE NEWSWIRE) -- 致力成為腫瘤綜合療法發現與開發領域的領先企業、並在中美兩國均設有總部的創新生物製藥公司CBT Pharmaceuticals（CBT）今日宣佈，公司將採用一套全新的全球領導層架構，並任命Yuling Li博士擔任工藝開發與製造高級副總裁。 ...
CBT Pharmaceuticals公布管理层新架构，旨在推动全球发展
August 16, 2018 09:50 ET
|
CBT Pharmaceuticals
美国加利福尼亚州普莱森顿, Aug. 16, 2018 (GLOBE NEWSWIRE) -- 讯：致力于成为肿瘤综合疗法发现与开发领域的领军者并在中美两国均设有总部的创新性生物制药公司CBT Pharmaceuticals（CBT）今日宣布，公司将采用一套新的全球管理层架构，并任命李玉玲（Yuling Li）博士担任工艺开发与制造高级副总裁。 ...
CBT Pharmaceuticals Announces New Leadership Structure to Drive Global Expansion
August 16, 2018 09:50 ET
|
CBT Pharmaceuticals
PLEASANTON, Calif. and HANGZHOU, China, Aug. 16, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT), a U.S. and China-based innovative biopharmaceutical company committed to becoming a leader in the...
CBT Pharmaceuticals首獲澳洲倫理批准啟動APOLLO-1用於肝細胞性肝癌和腎細胞癌治療I/II期臨床試驗
August 08, 2018 08:50 ET
|
CBT Pharmaceuticals
美國加利福尼亞州普萊森頓及中國杭州, Aug. 08, 2018 (GLOBE NEWSWIRE) -- 致力於成為腫瘤綜合療法發現與開發領域的領先企業並在中美兩國均設有總部的創新性生物製藥公司CBT...
CBT Pharmaceuticals首获澳大利亚伦理批准启动APOLLO-1用于肝细胞性肝癌和肾细胞癌治疗I/II期临床试验
August 08, 2018 08:50 ET
|
CBT Pharmaceuticals
美国加利福尼亚州普莱森顿及中国杭州, Aug. 08, 2018 (GLOBE NEWSWIRE) -- 致力于成为肿瘤综合疗法发现与开发领域的领军者并在中美两国均设有总部的创新性生物制药公司CBT...
CBT Pharmaceuticals Receives First Australian Ethics Approval to Initiate APOLLO-1 Phase 1/2 Clinical Trial for Hepatocellular and Renal Cell Carcinoma
August 08, 2018 08:50 ET
|
CBT Pharmaceuticals
PLEASANTON, Calif. and HANGZHOU, China, Aug. 08, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT), a U.S. and China-based innovative biopharmaceutical company committed to becoming a leader in the...
CBT Pharmaceuticals Initiates Phase 1b Clinical Trial for Anti-PD-1 Antibody CBT-501-01 (genolimzumab injection) in Patients with Advanced Solid Tumors
July 26, 2018 08:50 ET
|
CBT Pharmaceuticals
PLEASANTON, Calif. and HANGZHOU, ZHEJIANG, China, July 26, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT), a U.S. and China-based innovative biopharmaceutical company committed to becoming a...